Precigen Inc (FRA:I5X)
€ 0.8505 0.017 (2.04%) Market Cap: 264.54 Mil Enterprise Value: 252.32 Mil PE Ratio: 0 PB Ratio: 5.71 GF Score: 45/100

Precigen Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 11:45PM GMT
Release Date Price: €1.47 (-0.51%)
Unidentified Analyst

I think we can get started. Good afternoon, everyone. It's a great day to be indoors today. Welcome to the Precigen presentation at the 41st Annual JPMorgan Healthcare Conference. My name is (inaudible), and I'm from the JPMorgan Healthcare Investment Banking Group. It's my pleasure today to be introducing you to President and CEO of Precigen, Helen Sabzevari.

Before we get started, I just wanted to highlight 2 ways to submit questions. For those of you online, feel free to submit questions on the webcast. And for those of you joining us today in person, we'll be hosting a Q&A session after the presentation in this room.

Thank you. Over to you, Helen.

Helen Sabzevari
Precigen, Inc. - President, CEO & Director

Thank you so much. Thank you very much. First of all, I wanted to thank the organizers at JPMorgan, and it's great to be back in person this year.

So with that, also I would like to start the presentation. And before I start at actual slides, I would like to mention that the -- I'm making some forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot